On May 10, the FDA released two discussion papers on the use of artificial intelligence and machine learning (AI/ML) in drug development and manufacturing. In a statement introducing the papers, Patrizia Cavazzoni, M.D., Director of the FDA Center for Drug Evaluation and Research,…
Source: www.medtechintelligence.com – Read more
FDA Releases Two Discussion Papers on Artificial Intelligence and Machine Learning in Drug Development and Manufacturing
Must Read
Cybersecurity funding to surge this financial year: Adapt
Following a year-on-year survey of 181 Australian Chief Information Security Officers (CISOs)...
